SPORE in Ovarian Cancer

Dr. Anexander Nikitin

Abstract

This core will produce genetically engineered mice prone to develop ovarian cancer for all Fox Chase SPORE projects. It will also be available to, investigators at other ovarian SPORE institutions. The mice produced will be used to study targeted therapy, detection, immunotherapy, drug resistance and prevention of ovarian cancer. Dr. Nikitin will also provide comprehensive pathology assessment of the experimental material. He will supervise advance pathology techniques, such as laser icrodissection and digital slide imaging.